Search

Issue
Title
Authors
Personalized approach to systemic treatment of bladder cancer: molecular and genetic markers and new therapeutic strategies (literature review)
Lyubchenko L.N., Ghazaryan K.A., Chernavina K.M., Zaborskiy I.N., Kаryakin O.B., Kaprin A.D.
Narrative review of dissertation research and innovations in Russian science (2012–2024) on malignant kidney tumors
Vorobev V.А., Mickevich D.S., Baklanova O.V., Akperov G.R., Popov I.P.
Neoadjuvant targeted therapy in patients with renal cell carcinoma
Alekseev B.Y., Nyushko K.M., Kalpinsky A.S.
Results and analysis of the application of a consistent targeted therapy in patients with metastatic renal cell carcinoma in Moscow (for the period from June 2005 to July 2015)
Shirokorad V.I., Kolesnikov G.P., Kostritskiy S.V., Kashintsev K.Y., Dolgikh D.V.
Evaluation of the efficiency of combination palliative treatment in patients with metastatic clear-cell renal cell carcinoma
Borisov P.S., Orlova R.V., Shkolnik M.I., Karlov P.A.
Assessment of kidney injury during immune-targeted therapy (pembrolizumab + axitinib) in patients with metastatic renal cell carcinoma and solitary kidney
Titov K.S., Epifanova M.V., Alimov A.A., Shutov E.V., Nesterova O.Y., Lebedev S.S., Zapirov G.M.
Capabilities of preoperative targeted therapy in treatment of bone metastases in renal cancer
Yurmazov Z.A., Lushnikova N.A., Spirina L.V., Usynin E.A., Slonimskaya E.M., Anisenya I.I., Bogoutdinova A.V.
Possibilities of optimization of the second line targeted therapy for metastatic renal cell carcinoma
Markova A.S., Matveev V.B.
A new alternating regimen in metastatic renal cell carcinoma presented through a clinical case
Sayapina M.S., Shiryaev S.V., Krylov A.S., Ryzhkov A.D., Titov D.A., Nosov D.A.
Palliative nephrectomy until targeted therapy of disseminated kidney cancer patients
Klimov A.V., Volkova M.I., Shirokograd V.I., Kalinin S.A., Peters M.V., Matveev V.B.
CHEMOTHERAPY FOR HORMONE REFRACTORY PROSTATE CANCER
Gridneva Y.V., Matveev V.B., Bukharkin B.V., Kupchan D.Z.
PROGNOSTIC VALUE OF VHL GENE ALTERATION IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
Nosov D.A., Yakovleva E.S., Fedyanin M.Y., Chekini D.A., Sinitsyna M.N., Savelov N.A., Mikhailenko D.S., Zaletayev D.V., Lyubchenko L.N., Tjulandin S.A.
Nephrotoxicity of combination drug therapy in metastatic renal cancer
Titov K.S., Shutov E.V., Alimov A.A., Lebedev S.S., Kirichek A.A., Zapirov G.M.
Clinical experience in using sorafenib in patients with advanced kidney cancer
Zyryanov A.V., Oshchepkov V.N., Burkhanova L.A.
Interim results of targeted therapy of patients with metastatic kidney cancer in Moscow (for the period from June 2005 to July 2015)
Shirokorad V.I., Makhson A.N., Rusakov I.G., Kolesnikov G.P., Kostritskiy S.V., Kashintsev K.Y., Borisov V.I., Popov M.I., Shchupak M.Y., Kirdakova N.V., Mishugin S.V., Maturov M.R., Vinogradskiy A.G., Shikhov S.D., Gaydamaka E.V., Apol’skaya N.A., Shushakov M.U., Babaev E.R., Vorontsova A.A., Ivanov A.M., Amosov F.R.
Prognostic factors of the therapeutic efficacy of mTOR and VEGFR inhibitors in patients with metastatic renal cell carcinoma
Voroshilova Е.А., Apanovich N.V., Nosov D.A., Karpukhin А.V., Sokolova I.N., Fedyanin M.Y.
OPTIMIZATION OF SECOND-LINE TARGETED THERAPY FOR METASTATIC RENAL CELL CARCINOMA CANCER AFTER USE OF VEGF RECEPTOR – TYROSINE KINASE INHIBITORS (LITERATURE REVIEW)
Savkov R.V.
PROGNOSTIC VALUE OF MOLECULAR GENETIC MARKERS IN KIDNEY CANCER PATIENTS RECEIVING TARGETED THERAPY
Peters M.V., Shevchenko V.E., Matveev V.B., Volkova M.I., Kalinin S.A., Mikhailenko D.M., Zaletayev D.V.
Biomarkers determining treatment tactics in metastatic urothelial cancer
Grivtsova L.Y., Karyakin O.B., Syadrin M.G., Samborsky S.M., Ivanov S.A., Kaprin A.D.
Therapeutic effects of pazopanib treatment in patients with metastatic kidney cancer in real clinical practice
Berezin P.G., Milovanov V.V., Ivannikov A.A., Ognerubov N.A.
Targeted therapy of advanced renal cell carcinoma
Popov A.M.
THE AUTHOR’S EXPERIENCE IN USING BEVACIZUMAB PLUS INTERFERON ALFA-2A IN PATIENTS WITH DISSEMINATED RENAL CELL CARCINOMA
Popov A.M., Karyakin O.B., Gorban N.A.
SEQUENTIAL TARGETED THERAPY FOR DISSEMINATED KIDNEY CANCER
Matveev V.B., Volkova M.I.
Quality-adjusted time without symptoms or toxicity (Q-TWiST) for lenvatinib plus everolimus versus everolimus monotherapy in patients with advanced renal cell carcinoma
Lee C.H., Wan Y., Smith A., Xie R., Motzer R.J.
Renal cell carcinoma: What’s new in 2018
Matveev V.B., Markova A.S.
Targeted therapy in patients with poor-prognosis renal cell carcinoma
Alekseev B.Y., Kalpinskiy A.S., Mukhomed’yarova A.A., Nyushko K.M., Kaprin A.D.
Clinical economic assessment of the use of pazopanib in the therapy of disseminated kidney cancer
Zyryanov S.K., Frolov M.Y., Dyakov I.N.
Sorafenib is the first targeted agent to treat metastatic kidney cancer
Matveev V.B., Chernyaev V.A.
MOLECULAR BIOLOGICAL FACTORS OF PROGNOSIS AND EFFICIENCY OF MEDICAL TREATMENT FOR DISSEMINATED RENAL CELL CARCINOMA
Nosov D.A., Yakovleva E.S., Atayeva D.A., Lyubchenko L.N., Tyulyandin S.A.
USE OF A COMBINATION OF АVASTIN AND LOW-DOSE INTERFERON- α IN THE FIRST-LINE TREATMENT OF METASTATIC RENAL-CELL CANCER
Kalpinsky A.S., Alekseyev B.Y., Kaprin A.D.
CURRENTLY AVAILABLE TREATMENT OPTIONS FOR METASTATIC RENAL CELL CARCINOMA
Alekseev B.Y., Kaprin A.D., Kolesnikov G.P., Mukhomed’yarova A.A., Konopleva E.I., Kalpinskiy A.S.
Use of sunitinib in patients with metastatic kidney cancer in real clinical practice
Alekseev B.Y., Nyushko K.M., Kalpinsky A.S.
A case of treatment in a patient with synchronous bilateral renal cell carcinoma and simultaneous metastatic involvement of both adrenal glands: Clinical observation
Latypov V.R., Dambaev G.T., Popov O.S., Latypova V.N.
SEQUENTIAL USE OF TARGET AGENTS AND THEIR COMBINATION IN THE TREATMENT FOR METASTATIC RENAL CELL CARCINOMA
Alekseyev B.Y., Kalpinsky A.S.
THE FIRST RESULTS OF TARGETED THERAPY FOR KIDNEY CANCER IN MOSCOW
Shirokorad V.I., Makhson A.N., Borisov V.I., Minakova L.R., Popov M.I., Shchupak M.Y., Kirdakova N.V., Mishugin S.V., Maturov M.R., Vinogradsky A.G., Shikhov S.D., Gaidamaka E.V., Apolskaya N.A., Shushakov M., Babaev E.R., Vorontsova A.A., Ivanov A.M., Amosov F.R., Kolesnikov G.P.
Renal cell carcinoma: what’s new in 2019
Evsyukova О.I., Matveev V.В.
Individual approach in choosing second-line targeted therapy for metastatic renal cell carcinoma
Alekseev B.Y., Shevchuk I.M., Kaprin A.D.
Clinical and economic analysis of the 1st and 2nd target lines
D’yakov I.N., Zyryanov S.K.
Current treatment approach to non-clear cell renal carcinoma
Tsimafeyeu I.V.
Axitinib in the successive targeted therapy of patients with metastatic kidney cancer
Alekseev B.Y., Kalpinsky A.S., Nyushko K.M., Kaprin A.D.
EFFICIENCY OF TARGETED THERAPY USED IN THE HETEROGENEOUS POPULATION OF PATIENTS WITH METASTATIC KIDNEY CANCER
Alekseev B.Y., Kalpinsky A.S.
IDENTIFICATION OF PROGNOSTIC FACTORS OF THE EFFICIENCY OF BEVACIZUMAB THERAPY IN PATIENTS WITH METASTATIC RENAL-CELL CANCER
Alekseyev B.Y., Kalpinsky A.S., Nyushko K.M., Klimenko A.A., Anzhiganova Y.V., Varlamov S.A., Bichurina S.A., Vasilyev L.A., Arkhipov A.V., Gurina L.I., Leonov O.V.
Pancreatic metastases from renal cancer: comparing surgery and pharmacotherapy efficacy
Kotelnikov A.G., Kriger A.G., Podluzhny D.V., Proskuryakov I.S., Galkin G.V., Patyutko Y.I., Fainstein I.A.
Review of the Proceedings of the European Society for Medical Oncology (ESMO) 2017 Congress
Kirichek A.A., Kamolov B.S., Matveev V.B.
Combined treatment of metastatic renal cell carcinoma in spine
Shirokorad V.I., Kostritskii S.V., Zaborovskiy N.S., Ptashnikov D.A.
Long-term disease control in advanced renal cell cancer with brain metastases with pazopanib (case report and literature review)
Chernova V.V., Volodina L.N., Grigoriev A.V., Smirnov A.I., Shustova E.V., Zhuravlеva O.P., Bublikova M.P., Vizhgorodskaya V.V., Shomovа M.V., Matyash M.G.
Metastatic kidney cancer: Choice of first-line therapy
Alekseev B.Y.
СLINICAL EXAMPLES OF THE EFFICACY OF BEVACIZUMAB + INTERFERON-ALPHA IN LOW DOSES IN PATIENTS WITH ADVANCED RENAL CELL CARCINOMA
Popov A.M., Karyakin O.B.
USE OF TARGET DRUGS IN A HETEROGENEOUS POPULATION OF PATIENTS WITH METASTATIC KIDNEY CANCER
Alekseev B.Y., Kalpinskiy A.S.
Current advances in kidney cancer immunotherapy
Korotaeva A.A., Apanovich N.V., Braga E.A., Matveev V.B., Karpukhin A.V.
Metastatic renal cell carcinoma kidney in children 10 years old – possibility of targeted therapy
Pavlov A.Y., Sabirzyanova Z.R., Zheludkova O.G., Mikhalchenko A.V.
Optimization of sequential targeted therapy
Alekseev B.Y., Kalpinskiy A.S., Nyushko K.M., Taraki I.A., Kaprin A.D.
Current idea of an algorithm for drug treatment and optimal succession of using targeted drugs
Nosov D.A., Voroshilova E.A., Sayapina M.S.
ЭФФЕКТИВНОСТЬ СУНИТИНИБА В ТАРГЕТНОЙ ТЕРАПИИ МЕТАСТАТИЧЕСКОГО РАКА ПОЧКИ
,
1 - 54 of 54 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"